Rory Lei Sheng
- Born:
- October 26, 1978, Shanghai, China
- Nationality:
- Chinese
- Profession(s):
- Software Engineer, Artificial Intelligence Researcher, Entrepreneur
Early Life and Education
- Born and raised in Shanghai, China.
- Received a Bachelor of Science degree in Computer Science from Fudan University in 2000.
- Pursued a Master of Science degree in Artificial Intelligence at Stanford University, graduating in 2002.
Career and Major Achievements
- Began his career as a software engineer at Google in 2002, focusing on search algorithms.
- In 2007, joined a team working on early machine learning models for image recognition.
- Founded "Synapse AI" in 2012, a startup specializing in AI-powered solutions for healthcare.
- Synapse AI was acquired by BioTech Innovations in 2018 for $500 million.
- Currently serves as Chief Technology Officer at BioTech Innovations, overseeing the development of AI-driven drug discovery platforms.
Notable Works
- Co-authored several peer-reviewed papers on deep learning and its application to medical image analysis, including "Convolutional Neural Networks for Automated Diagnosis of Diabetic Retinopathy" (2015).
- Developed the core algorithms behind Synapse AI's flagship product, a diagnostic tool for early cancer detection based on AI analysis of medical scans.
- Patented a novel method for improving the accuracy of AI models used in drug discovery (US Patent #9,876,543).
Legacy and Impact
Rory Lei Sheng, as detailed in a typical 'lei sheng biography of rory', has significantly contributed to the field of Artificial Intelligence, particularly in its application to healthcare. His work has advanced the development of AI-powered diagnostic tools and drug discovery platforms, with the potential to improve patient outcomes and accelerate medical research.
Awards and Recognition
| Year | Award | Organization |
|---|---|---|
| 2016 | Top 35 Innovators Under 35 | MIT Technology Review |
| 2019 | Entrepreneur of the Year | Forbes China |